Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Modeling and simulation approaches to evaluate pharmacokinetic sampling contamination from central venous catheters in pediatric pharmacokinetic studies of actinomycin-D: a report from the children's oncology group.

Edwards AY, Skolnik JM, Dombrowsky E, Patel D, Barrett JS.

Cancer Chemother Pharmacol. 2012 Jul;70(1):83-94. doi: 10.1007/s00280-012-1878-y. Epub 2012 May 24.

PMID:
22623208
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Approaches to clear residual chemotherapeutics from indwelling catheters in children with cancer.

Skolnik JM, Zhang AY, Barrett JS, Adamson PC.

Ther Drug Monit. 2010 Dec;32(6):741-8. doi: 10.1097/FTD.0b013e3181fa3c68.

PMID:
20962707
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Population pharmacokinetic investigation of actinomycin-D in children and young adults.

Mondick JT, Gibiansky L, Gastonguay MR, Skolnik JM, Cole M, Veal GJ, Boddy AV, Adamson PC, Barrett JS.

J Clin Pharmacol. 2008 Jan;48(1):35-42.

PMID:
18094218
[PubMed - indexed for MEDLINE]
4.

Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.

Kontny NE, Würthwein G, Joachim B, Boddy AV, Krischke M, Fuhr U, Thompson PA, Jörger M, Schellens JH, Hempel G.

Cancer Chemother Pharmacol. 2013 Mar;71(3):749-63. doi: 10.1007/s00280-013-2069-1. Epub 2013 Jan 13.

PMID:
23314734
[PubMed - indexed for MEDLINE]
5.
6.

Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group.

Thompson PA, Gupta M, Rosner GL, Yu A, Barrett J, Bomgaars L, Bernstein ML, Blaney SM, Mondick J.

Cancer Chemother Pharmacol. 2008 Nov;62(6):1027-37. doi: 10.1007/s00280-008-0692-z. Epub 2008 Feb 16.

PMID:
18278496
[PubMed - indexed for MEDLINE]
7.

Pharmacokinetic properties of infliximab in children and adults with Crohn's disease: a retrospective analysis of data from 2 phase III clinical trials.

Fasanmade AA, Adedokun OJ, Blank M, Zhou H, Davis HM.

Clin Ther. 2011 Jul;33(7):946-64. doi: 10.1016/j.clinthera.2011.06.002. Epub 2011 Jul 7.

PMID:
21741088
[PubMed - indexed for MEDLINE]
8.

Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia.

Aumente D, Buelga DS, Lukas JC, Gomez P, Torres A, García MJ.

Clin Pharmacokinet. 2006;45(12):1227-38.

PMID:
17112298
[PubMed - indexed for MEDLINE]
9.

Population pharmacokinetics of APOMINE: a meta-analysis in cancer patients and healthy males.

Bonate PL, Floret S, Bentzen C.

Br J Clin Pharmacol. 2004 Aug;58(2):142-55.

PMID:
15255796
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.

Delattre IK, Musuamba FT, Nyberg J, Taccone FS, Laterre PF, Verbeeck RK, Jacobs F, Wallemacq PE.

Ther Drug Monit. 2010 Dec;32(6):749-56. doi: 10.1097/FTD.0b013e3181f675c2.

PMID:
20962708
[PubMed - indexed for MEDLINE]
11.

Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.

Chhun S, Jullien V, Rey E, Dulac O, Chiron C, Pons G.

Epilepsia. 2009 May;50(5):1150-7. doi: 10.1111/j.1528-1167.2008.01974.x. Epub 2009 Jan 19.

PMID:
19175400
[PubMed - indexed for MEDLINE]
12.

Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study.

Veal GJ, Cole M, Errington J, Parry A, Hale J, Pearson AD, Howe K, Chisholm JC, Beane C, Brennan B, Waters F, Glaser A, Hemsworth S, McDowell H, Wright Y, Pritchard-Jones K, Pinkerton R, Jenner G, Nicholson J, Elsworth AM, Boddy AV; Kingdom Children's Cancer Study Group Pharmacology Working Group.

Clin Cancer Res. 2005 Aug 15;11(16):5893-9.

PMID:
16115931
[PubMed - indexed for MEDLINE]
Free Article
13.

Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.

Anderson BJ, Pons G, Autret-Leca E, Allegaert K, Boccard E.

Paediatr Anaesth. 2005 Apr;15(4):282-92.

PMID:
15787918
[PubMed - indexed for MEDLINE]
14.

Central venous catheter sampling of low molecular heparin levels: an approach to increasing result reliability.

Bauman ME, Belletrutti M, Bauman ML, Massicotte MP.

Pediatr Crit Care Med. 2012 Jan;13(1):1-5. doi: 10.1097/PCC.0b013e31820ac2f6.

PMID:
21317677
[PubMed - indexed for MEDLINE]
15.
16.

Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases.

Hong Y, Shaw PJ, Nath CE, Yadav SP, Stephen KR, Earl JW, McLachlan AJ.

Antimicrob Agents Chemother. 2006 Mar;50(3):935-42.

PMID:
16495254
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.

Zhou H, Mayer PR, Wajdula J, Fatenejad S.

J Clin Pharmacol. 2004 Nov;44(11):1235-43.

PMID:
15496641
[PubMed - indexed for MEDLINE]
18.

Refinement of the population pharmacokinetic model for the monoclonal antibody matuzumab: external model evaluation and simulations.

Kuester K, Kovar A, Lüpfert C, Brockhaus B, Kloft C.

Clin Pharmacokinet. 2009;48(7):477-87. doi: 10.2165/11313400-000000000-00000.

PMID:
19691369
[PubMed - indexed for MEDLINE]
19.

Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study.

Hennig S, Norris R, Kirkpatrick CM.

Br J Clin Pharmacol. 2008 Apr;65(4):502-10. Epub 2007 Nov 8.

PMID:
17995972
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants.

Cohen-Wolkowiez M, Ouellet D, Smith PB, James LP, Ross A, Sullivan JE, Walsh MC, Zadell A, Newman N, White NR, Kashuba AD, Benjamin DK Jr.

Antimicrob Agents Chemother. 2012 Apr;56(4):1828-37. doi: 10.1128/AAC.06071-11. Epub 2012 Jan 17.

PMID:
22252819
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk